The burden of isoniazid-resistant tuberculosis (Hr-TB) and multidrug-and/or rifampicin
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …

Background: Characteristics and treatment outcomes of patients with drug-resistant
tuberculosis (DR TB) before introduction of directly observed treatment strategy (DOTS) plus …

Emergence of extensively drug-resistant tuberculosis (XDR-TB) has significantly threatened
to jeopardize global efforts to control TB, especially in HIV endemic regions. XDR-TB is …

An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died
from the disease. Although antibiotics to treat TB were developed in the 1950s and are …

Multi-Drug Resistant Tuberculosis (MDR-TB) is a growing hazard to human health world
wide and threat to control of tuberculosis. Current estimates report the prevalence of primary …

National tuberculosis programmes (NTPs) should aim for achieving a very high proportion of
cure of all tuberculosis (TB) cases. Ineffective chemotherapy of TB that keeps a substantial …

In the early weeks of January 2012, a report of four cases of tuberculosis from Mumbai,
India, stirred up a storm. 1 India bears a giant's share of the world's multidrug-resistant …

Multi-drug and extensively drug resistant tuberculosis (M/XDR-TB) has been an area of
growing concern among clinicians, epidemiologists, and public health workers worldwide …

Multidrug resistant tuberculosis (MDR-TB) has been an area of growing concern and is
posing a threat to the control of tuberculosis (TB). The exact magnitude of problem of …

42 The Journal of Association of Chest Physicians| Jul-Dec 2016| Vol 4| Issue 2 experience
with these new drugs in the country which most urgently needs to have them available [9]• …